Stroke Prevention in Patients with Atrial Fibrillation

Trial ID:
IRB-21-7811
Douglas Gibson, M.D.
This study will compare if left atrial appendage (LAA) closure with the WATCHMAN FLX Device is a
reasonable alternative to long-term oral anticoagulation (OAC) therapy (blood thinner medication) to prevent strokes in patients with atrial fibrillation (A-Fib).
*Be 18 years of age or older<br>*Have atrial fibrillation <br>*Be suitable for medication regimens<br>*Be able and willing to return for required follow-up visits and examinations

Contact Info:

  • Clinical Research Services
  • CRSLeadership@scrippshealth.org